The Cooper Companies, Inc. (COO) – What Are Researchers Saying About This Stock?

The Cooper Companies, Inc. (NASDAQ:COO) has been assigned an average recommendation of “Hold” from the nineteen research firms that are covering the stock, MarketBeat reports. Two analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and four have assigned a buy rating to the company. The average 1-year price target among brokerages that have covered the stock in the last year is $68.60.

A number of analysts have recently commented on COO shares. Robert W. Baird set a $61.00 price target on Cooper Companies and gave the company a “neutral” rating in a research note on Thursday, September 10th. Stifel Nicolaus set a $70.00 price target on Cooper Companies and gave the stock a “buy” rating in a report on Thursday, September 10th. Wall Street Zen downgraded Cooper Companies from a “buy” rating to a “hold” rating in a research note on Saturday, September 12th. Bank of America reaffirmed a “neutral” rating and issued a $65.00 price objective (down from $80.00) on shares of Cooper Companies in a research note on Thursday, September 10th. Finally, Wells Fargo & Company set a $61.00 price objective on shares of Cooper Companies and gave the company an “equal weight” rating in a report on Thursday, September 10th.

Insiders Place Their Bets

In other Cooper Companies news, Director Walter M. Rosebrough, Jr. purchased 3,000 shares of the firm’s stock in a transaction on Monday, September 14th. The stock was purchased at an average cost of $54.29 per share, for a total transaction of $162,870.00. Following the transaction, the director owned 20,000 shares in the company, valued at $1,085,800. The trade was a 17.65% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Lawrence Kurzius purchased 10,000 shares of the company’s stock in a transaction dated Wednesday, September 16th. The shares were acquired at an average cost of $54.93 per share, with a total value of $549,300.00. Following the purchase, the director directly owned 31,099 shares of the company’s stock, valued at approximately $1,708,268.07. The trade was a 47.40% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders have acquired 34,701 shares of company stock valued at $1,880,039 in the last ninety days. 2.08% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Cooper Companies

Several hedge funds and other institutional investors have recently modified their holdings of the company. BlackRock Inc. bought a new position in shares of Cooper Companies in the 2nd quarter worth $1,077,762,000. Generation Investment Management LLP bought a new stake in Cooper Companies during the 2nd quarter valued at $356,304,000. Jupiter Topco LLC bought a new stake in Cooper Companies during the 2nd quarter valued at $305,074,000. Bank of America Corp DE bought a new stake in Cooper Companies during the 2nd quarter valued at $144,125,000. Finally, Manning & Napier Advisors LLC bought a new stake in Cooper Companies during the 2nd quarter valued at $107,939,000. Institutional investors own 24.39% of the company’s stock.

Cooper Companies Trading Up 1.7%

NASDAQ COO opened at $59.12 on Wednesday. The company has a quick ratio of 0.73, a current ratio of 1.22 and a debt-to-equity ratio of 0.23. Cooper Companies has a twelve month low of $51.01 and a twelve month high of $89.83. The company has a market cap of $11.24 billion, a price-to-earnings ratio of 20.18, a price-to-earnings-growth ratio of 2.37 and a beta of 0.83. The business’s fifty day moving average is $62.74 and its 200 day moving average is $65.94.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings data on Wednesday, September 9th. The medical device company reported $1.15 earnings per share for the quarter, topping analysts’ consensus estimates of $1.12 by $0.03. Cooper Companies had a return on equity of 10.90% and a net margin of 13.46%. The business had revenue of $1.07 billion for the quarter, compared to analyst estimates of $1.10 billion. During the same quarter in the previous year, the company posted $0.49 EPS. Cooper Companies’s quarterly revenue was up .5% compared to the same quarter last year. Cooper Companies has set its Q4 2026 guidance at 1.050-1.090 EPS and its FY 2026 guidance at 4.510-4.550 EPS. As a group, sell-side analysts expect that Cooper Companies will post 4.53 EPS for the current fiscal year.

Cooper Companies announced that its board has approved a stock repurchase program on Wednesday, September 9th that allows the company to buy back $3.00 billion in shares. This buyback authorization allows the medical device company to buy up to 22.7% of its stock through open market purchases. Stock buyback programs are usually a sign that the company’s leadership believes its stock is undervalued.

Cooper Companies Company Profile

CooperCompanies is a global medical device company that develops, manufactures and markets products for vision care and women’s health. The company operates through two primary business segments: CooperVision and CooperSurgical.

CooperVision provides contact lenses and related technologies, including products designed for myopia management, astigmatism, presbyopia and other vision-correction needs. Its portfolio includes daily disposable, reusable and specialty contact lenses sold through eye-care professionals and distributors.

CooperSurgical develops products and services for fertility and women’s health.